TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
25 hedge funds and large institutions have $140K invested in TetraLogic Pharmaceuticals Corporation in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 12 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
19% less funds holding
Funds holding: 31 → 25 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
99% less capital invested
Capital invested by funds: $10.2M → $140K (-$10M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$48.3K |
| 2 |
Lazard Asset Management
New York
|
+$20.8K |
| 3 |
GA
Geneva Advisors
Chicago,
Illinois
|
+$14.6K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$13.7K |
| 5 |
Goldman Sachs
New York
|
+$7.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
-$8.04M |
| 2 |
FWC
First Washington Corp
Seattle,
Washington
|
-$549K |
| 3 |
First Eagle Investment Management
New York
|
-$346K |
| 4 |
NC
Nexthera Capital
New York
|
-$111K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$54K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ARTA
26
A.R.T. Advisors
New York
| – | -$24K | -14,358 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$10K | -6,008 | Closed |
|
|
BJ
28
BlackRock Japan
Tokyo,
Japan
| – | -$7K | -4,222 | Closed |
|
29
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$2K | -1,000 | Closed |
|
30
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$2K | -1,000 | Closed |
|
31
Wells Fargo
San Francisco,
California
| – | -$2K | -1,000 | Closed |
|
32
Citigroup
New York
| – | +$76 | +275 | New |
|
|
BFA
33
BlackRock Fund Advisors
San Francisco,
California
| – | +$86 | +308 | +21% |
|
TLOG Hedge Fund Activity: Q1 2016 in Review
25 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q1 2016, worth a combined $140K — down 99% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TLOG and 6 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $48.3K. The largest seller was Clarus Ventures, exiting entirely with an estimated $8.04M sold.
- 25 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q1 2016, down from 31 in Q4 2015.
- Funds reported $140K of TetraLogic Pharmaceuticals Corporation stock for Q1 2016, down 99% quarter-over-quarter.
- 6 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q1 2016 and 12 closed out, a net change of -6 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q1 2016 was Renaissance Technologies, an estimated $48.3K added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q1 2016 was Clarus Ventures, an estimated $8.04M sold.
Based on aggregated 13F filings for Q1 2016.